Talledo, Jerma M.

HRN: 11-64-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2026
CEFTRIAXONE 1G (VIAL)
07/04/2026
07/11/2026
IV
2g
OD
UTI, CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines